𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetics and tolerance of intravenous and intramuscular recombinant alpha2 interferon in patients with malignancies

✍ Scribed by I. Shah; J. Band; M. Samson; J. Young; R. Robinson; B. Bailey; A. Martin Lerner; A. S. Prasad


Publisher
John Wiley and Sons
Year
1984
Tongue
English
Weight
467 KB
Volume
17
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Recombinant alpha-2b-interferon enhances
✍ Giovanni Scambia; Pierluigi Benedetti Panici; Stefano Iacobelli; Gabriela Baiocc πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 372 KB πŸ‘ 2 views

The circulating levels of a 90-kilodalton (K) tumor-associated antigen were measured in the blood of 43 patients with gynecologic and breast malignancies who underwent a short course of recombinant alpha-2b-interferon (rIFN a-zb) (3 million U/m2/d intramuscularly [IM] for 3 days). Of the 43 patients

Pulmonary side effects of interferon-Ξ± t
✍ Patrik Anderson; Martin HΓΆglund; Stig RΓΆdjer πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 56 KB πŸ‘ 1 views

## Abstract Several side effects of interferon‐α‐2b (IFN‐α) therapy have been described. Pulmonary side effects have seldom been reported. The four patients we describe all developed respiratory disorders while being treated with IFN‐α for hematological malignancies. We point out the similarities a